POLO: Efficacy and health-related quality of life (HRQOL) with maintenance olaparib following first-line platinum-based chemotherapy (PBC) in patients (PTS) with a germline BRCA mutation and metastatic pancreatic cancer (MPC) Meeting Abstract
| Authors: | Reinacher-Schick, A. C.; Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Mercade, T. M.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Oh, D. Y.; Tortora, G.; Algul, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K.; Schlienger, K.; Locker, G. Y.; Golan, T.; Arnold, D. |
| Abstract Title: | POLO: Efficacy and health-related quality of life (HRQOL) with maintenance olaparib following first-line platinum-based chemotherapy (PBC) in patients (PTS) with a germline BRCA mutation and metastatic pancreatic cancer (MPC) |
| Meeting Title: | 34. Deutscher Krebskongress (DKK) |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 43 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Feb 19-22 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2020-02-01 |
| Start Page: | 68 |
| Language: | English |
| ACCESSION: | WOS:000517158700167 |
| PROVIDER: | wos |
| DOI: | 10.1159/000506491 |
| Notes: | "34th German Cancer Congress" -- Meeting Abstract: 992 -- Source: Wos |
